The application of Quality by Design (QbD) has become second nature to the pharmaceutical industry. The resulting benefits prompt the question of whether QbD principles are applicable to other processes and analytical method development is now a focus. Just like conventional QbD, analytical QbD (AQbD) holds out the prize of flexibility, in contrast to the rigidity of Standard Operating Procedures (SOPs).
This whitepaper introduces AQbD and examines how the process of developing and validating analytical methods can benefit from the systematic and scientific approach that QbD promotes.
Download this whitepaper to:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy